Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M, Xie J, Xing Y, Zhang L, Chen H, Tang B, Zhou M, Lv S, Huang D, Jian S, Zhou C, Liu M, Guo W, Chen Y, Yi Z.
Wu M, et al. Among authors: tang b.
Int J Biol Sci. 2024 Jan 1;20(2):486-501. doi: 10.7150/ijbs.86303. eCollection 2024.
Int J Biol Sci. 2024.
PMID: 38169532
Free PMC article.